Variant report
Variant | esv3508499 |
---|---|
Chromosome Location | chr4:171690271-171722702 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs35512771 | chr4:171691260-171691261 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs538916746 | chr4:171691265-171691266 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs547598331 | chr4:171691272-171691273 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs565917833 | chr4:171691276-171691277 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs186612108 | chr4:171691305-171691306 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs555043626 | chr4:171691373-171691374 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs576398821 | chr4:171691394-171691395 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs560293060 | chr4:171691416-171691417 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs539630397 | chr4:171691419-171691420 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs537463527 | chr4:171691522-171691523 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs10004230 | chr4:171691525-171691526 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs576379318 | chr4:171691541-171691542 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs541864333 | chr4:171691573-171691574 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs541299604 | chr4:171691614-171691615 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs559623554 | chr4:171691629-171691630 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs7673001 | chr4:171691630-171691631 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs571942125 | chr4:171691649-171691650 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs541609917 | chr4:171691666-171691667 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs34425817 | chr4:171691712-171691713 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs563390148 | chr4:171691737-171691738 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs530475022 | chr4:171691756-171691757 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs375120243 | chr4:171691791-171691792 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs139413312 | chr4:171691798-171691799 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs191349065 | chr4:171691812-171691813 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs532699920 | chr4:171691831-171691832 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs78723475 | chr4:171691870-171691871 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs565979275 | chr4:171691886-171691887 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs183755902 | chr4:171691906-171691907 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs28482955 | chr4:171691912-171691913 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs189078245 | chr4:171691937-171691938 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs372211033 | chr4:171691953-171691954 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs192817696 | chr4:171691972-171691973 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs376729990 | chr4:171691976-171691977 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs80071253 | chr4:171692038-171692039 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs150061527 | chr4:171692083-171692084 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs553304003 | chr4:171692101-171692102 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs574729792 | chr4:171692127-171692128 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs542008774 | chr4:171692140-171692141 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs72696893 | chr4:171692146-171692147 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs140904005 | chr4:171692197-171692198 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs4472098 | chr4:171692211-171692212 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs144750349 | chr4:171692219-171692220 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs185235422 | chr4:171692229-171692230 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs541365565 | chr4:171692240-171692241 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs78567784 | chr4:171692299-171692300 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs4473624 | chr4:171692300-171692301 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs147909608 | chr4:171692321-171692322 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs111728773 | chr4:171692363-171692364 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs71607816 | chr4:171692364-171692365 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs113744158 | chr4:171692427-171692428 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 16272173 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Breast cancer | 21785460 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21633010 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20581869 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Neuroblastoma | 16790693 | CNVD |
Developmental delay | 22127048 | CNVD |
Schizophrenia | 23813976 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:171691200-171691400 | Enhancers | Placenta Amnion | Placenta Amnion |
2 | chr4:171691400-171692800 | Weak transcription | Placenta Amnion | Placenta Amnion |
3 | chr4:171692800-171694200 | Enhancers | Placenta Amnion | Placenta Amnion |
4 | chr4:171696800-171697000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr4:171697600-171698400 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
6 | chr4:171698200-171698400 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
7 | chr4:171698200-171698600 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
8 | chr4:171698200-171698600 | Enhancers | GM12878-XiMat | blood |
9 | chr4:171709400-171709600 | Enhancers | H1 Cell Line | embryonic stem cell |
10 | chr4:171709600-171710000 | Active TSS | H1 Cell Line | embryonic stem cell |
11 | chr4:171709600-171710200 | Active TSS | H9 Cell Line | embryonic stem cell |
12 | chr4:171709600-171710200 | Active TSS | HUES48 Cell Line | embryonic stem cell |
13 | chr4:171709600-171710200 | Active TSS | HUES64 Cell Line | embryonic stem cell |
14 | chr4:171709600-171710200 | Active TSS | iPS-15b Cell Line | embryonic stem cell |
15 | chr4:171709600-171710400 | Active TSS | HUES6 Cell Line | embryonic stem cell |
16 | chr4:171709800-171710200 | Active TSS | iPS-18 Cell Line | embryonic stem cell |
17 | chr4:171710000-171710200 | Enhancers | H1 Cell Line | embryonic stem cell |